Dr. Sashi Kiran Kode has established himself in various fields and specially the one when it is related to the medical one, Dr. Kiran brought his commitment and gifts as doctor and trainer to patients suffering from a wide range of maladies. He has achieved a confluence of medicine with the pharmaceutical industry, boosting both, and preventing duplication of research and the reinvention of the wheel. This interface between the two fields will make medicine more effective and the pharmaceutical industry more purposive.
Dr. Kiran began his career as an investigator in several research studies with a focus on India and its problems in offering high-quality medical treatment. Already with a Masters in Surgery, he had a revolutionary change in his life with a British Fellowship as he became deeply interested in head and neck cancers as well as thyroid disorders among other life-altering areas such as spinal injuries. Ever the researcher at the cutting edge of medicine, Dr. Kiran founded D2L in 2007. The company has now become a pioneer of research in medicine reaping rich rewards in the development of new drugs.
With not just the quality of a great researcher, he is a corporate strategy and development specialist with operational excellence. He has the power of effective leadership, possess high orientation and people skills. His work life has contributed in developing training modules for clinical operations at hospitals. He played a major role in training junior graduates and emergency staffs in the casualties. He has been an important surgeon and has prosecuted Gastroenterology surgeries at SVIMS Institute of Medical Sciences at Tirupati. He has always shown keen interest on various conferences like XX Annual Conference Karnataka State Chapter Association of Surgeons and The International Oncology Workshop. Dr. Kiran’s missions are the breakthrough to our society healthcare sector.
Deepak Harikrishnan has been the importance of D2L’s growth and reputation as a global company by positioning it the high end of the medical services spectrum. As the CEO and the co-founder of D2L, his farsightedness, thanks to his inherently visionary approach, has seen D2L make a name for itself in fields as different as clinical research, KOL analytics, data analytics, networking skills and market research. He has forged alliances that were the keystones in the arches of many business relationships in pharmaceuticals. His business strategies have been crucial in business turnarounds and have been manifested in an astonishing 200% growth of D2L over the last six years.
Deepak is the mastermind behind the Business Mapping Process and initiated the cost efficiency programs at all levels. He has successfully identified and drove revenue growth. He has been the jack to the entire marketing and sales operation. His delivery to the exceptional growth has helped to reach the top line of profit. He has been an innovative thinker in developing, identifying and directing the implementation of business strategies to experience and explore a whole new opportunities. He has proved himself as an effective leader with his exceptional planning and relationship management skills with being recognised several times in a global level. While breaking new avenues and driving new revenue growth he has proven his skills vibrantly. He has proactively conducted opportunity analysis and has achieved market share metrics. He has very strong networking skills with a very impactful international experience of developing and nurturing relationships across cultures and diversities. He is the man who has been behind the exponential growth of over 200 percent over the last five years beyond customer expectations. He is our choice for CEO of our US and Canada operations.
Shekhar Gupta’s rich experience in Business Intelligence and Clinical Research goes in tandem with his multifaceted abilities in all aspects that have made D2L a successful revenue generating company with a niche of its own in the market.
He is the Chief Operating Officer with credentials based with a graduation in Pharmacy and a PGD in Clinical Research from the University of Cranfield, UK.
Gupta’s forte has been his ability to conceptualize, and construct turnkey projects and lead them to success through a goal-driven approach that guarantees growth. Shekhar also plays a key role in KOL analytics adding his strengths from the clinical and analytical backgrounds. With deep knowhow of the clinical & KOL industry and extensive connections among the industry, he has been the major contributor to the increasing client base of D2L. He contributed immensely in the analytical and CRO spaces that helped D2L Pharma establish itself as a Global KOL leader. He strongly believes that keeping the team vibrant and joyful at D2L happy is the foremost factor for successful deliverables. He has an innate ability, honed by experience, to identify markets and opportunities for business growth. He has a very extraordinary reputation in the press and is also the mastermind behind the growth chart of the company. He has always been committed towards every single role he played for the company. All the workers have exhibited his leadership quality in the company.
Gupta’s consummate abilities are guarantees of a firm foundation for the Company and a bright future that promises growth and success.
Ravikant M has been a mastermind of the company which has led to the establishment of D2L in a Global level. He joined as the director with his strong driving vision to build D2L to a Global organization. He aims to combine the data, business needs and technical insights with powerful engagement models. His prior vision is to make D2L serve customers globally with relentless dedication to client satisfaction.
Ravi pioneered in developing new methodologies and bringing innovative systems into KOL mapping and identification which were greatly captivated by the Global Clientele. He was successful in understanding the client needs time to time and was leading the team deliver more than the client’s expectations. With his immense hard work and sincerity, he has set a benchmark in the Pharma industry. He has also designed the marketing mix platforms for the first time in India. Ravi was also greatly successful in developing the next level leadership in the team. Ravi heads the organization’s Decision Support Services as the Director of D2L. He has a very keen interest in market assessment and Key Opinion Leader Analytics (KOL).
He has also encompassed KOL analytics market research and forecasting. Ravi’s current profile includes his exceptional skill in not only business skills but also strategic decision making for the company. His new insights into KOL analytics with new technologies has been greatly appreciated by his clients. Ravi has shown his extraordinary sincerity to D2L which has brought D2L to such a huge Global platform and has recognized it in the Global Pharma industry and a successful future. In short, he is at the frontline of most operations and leadership in the Company.
Fulfill the clients needs with our services to meet their business demands
Contribute to the society with Corporate Activity based on high ethical standards
Appropriate Compensation based on work and performance and equitable support for Career development
D2L strongly believe that a well-trained and competent workforce is crucial for the development of any organization. To accomplish that, we always strive to fascinate and preserve employees of the highest caliber. At D2L we work with your leadership team to identify training needs, to design, develop, implement, and evaluate employee training and development programs to meet client’s strategic objectives. Training and Development can only take place when the resources are properly planned and budgeted in relevance to training.
If you are interested please send us your contact and resume.